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The mouse embryonal carcinoma cell line ATDC5 provides an excellent model system for chondrogenesis in vitro. To understand better the
molecular mechanisms of endochondral bone formation, we investigated gene expression profiles during the differentiation course of ATDC5
cells, using an in-house microarray harboring full-length-enriched cDNAs. For 28 days following chondrogenic induction, 507 genes were up- or
down-regulated at least 1.5-fold. These genes were classified into five clusters based on their expression patterns. Genes for growth factor and
cytokine pathways were significantly enriched in the cluster characterized by increases in expression during late stages of chondrocyte
differentiation. mRNAs for decorin and osteoglycin, which have been shown to bind to transforming growth factors-β and bone morphogenetic
proteins, respectively, were found in this cluster and were detected in hypertrophic chondrocytes of developing mouse bones by in situ
hybridization analysis. Taken together with assigned functions of individual genes in the cluster, interdigitated interaction between a number of
intercellular signaling molecules is likely to take place in the late chondrogenic stage for autocrine and paracrine regulation among chondrocytes,
as well as for chemoattraction and stimulation of progenitor cells of other lineages.
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of the cartilage template that is eventually converted into bone
[1]. This course is known as endochondral bone formation,
which is one of the most spectacular events in ontogeny. During
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The majority of hypertrophic chondrocytes appear to undergo
apoptosis and are replaced by bone and marrow with the
invasion of blood vessels, osteoprogenitor cells, and hemato-
poietic cells.
A number of secreted proteins such as Indian hedgehog,
parathyroid hormone-related protein, fibroblast growth factors
(FGFs), and bone morphogenetic proteins (BMPs) have been
shown to regulate cooperatively the proliferation and differen-
tiation of chondrocytes [1]. These secreted ligands regulate
expression of a large number of target genes, as typically
demonstrated by comprehensive gene expression analysis for
the targets of FGF [2] and BMP4 [3]. Recently, several
transcription factors including SOX [4,5] and Runx [6–8]
53A. Osawa et al. / Genomics 88 (2006) 52–64family members have been shown to be essential for endo-
chondral bone formation.
To understand better the global molecular basis of
endochondral bone formation, we investigated genes up- or
down-regulated during the proliferation and subsequent differ-
entiation of the mouse embryonal carcinoma cell line ATDC5,
which provides an excellent model system for chondrogenesis
[9,10]. We first constructed a full-length-enriched cDNA library
[11] derived from ATDC5 cells as well as mouse bone and
cartilage tissues and then prepared an in-house microarray
harboring these cDNAs. Subsequent array analysis revealed that
a number of genes for growth factor and cytokine pathways are
activated in the late phase of ATDC5 differentiation. Among
them, genes for decorin and osteoglycin, members of the small
leucine-rich proteoglycan (SLRP) family [12,13] for multifac-
eted extracellular matrix (ECM) proteins, were shown to be
expressed in hypertrophic chondrocytes displaying multiple
tasks in bone formation.
Results
Construction of the cDNA library and microarray
We constructed a full-length-enriched cDNA library using
the oligo-capping method [11] with RNAmixtures derived from
mouse chondrogenic ATDC5 cells and developing mouse
cartilage and bone tissues (Fig. 1). We determined 5′-endFig. 1. Schematic representation of construction of the in-house cDNA
microarray. Preparation of a mouse fetus (E14) cDNA library was described
previously [14]. A cDNA library derived from ATDC5 cells and mouse cartilage
and bone was prepared as described under Materials and methods. Indicated
numbers of cDNA clones of each library were subjected to sequence
determination and further to microarray construction after clustering analysis
and integrating genes shared by the two libraries. A microarray harboring 2913
cDNAs was constructed.sequences of 3680 cDNA clones in the library and compared
them with the NCBI nucleotide database using the BLAST
programs. The 3680 cDNA clones were assembled into 1920
clusters when overlapping clones were integrated. The library
was judged to be enriched with full-length cDNAs, since 68%
of the cDNA clones had the initiation ATG codon found in the
public databases. The average length of the cDNA insert was
approximately 2.0 kb.
To construct an in-house cDNA microarray, 1829 clones
were selected from the 1920 clusters and compared with 1614
clones of 1627 clusters derived from 3289 sequenced clones of
the mouse fetus (embryonic day 14 (E14)) cDNA library
described previously [14]. Integration of 530 shared genes gave
2913 clones, whose cDNA inserts were subjected to preparation
of the microarray (Supplementary Table 1). The NCBI BLAST
search revealed that 97.9% (2852 clones) of the 2913 clones
coincided with the known mouse mRNA/cDNA sequences, 29
clones with the mouse genome but not with mRNA/cDNA
sequences, and 32 clones did not coincide with known
sequences, while 22 of the 32 clones were apparently of bad
or short sequences.
Microarray analysis
We used the clonal cell line ATDC5 to track the stages of
chondrogenic differentiation. Undifferentiated ATDC5 cells
rapidly proliferated and ceased to grow at confluence. In the
differentiation medium containing 10 μg/ml insulin, the cells
reentered the growth state, with cellular condensation followed
by the formation of cartilage nodules being detected micro-
scopically (data not shown). Differentiation of ATDC5 cells into
chondrocytes and further into hypertrophic chondrocytes was
confirmed by monitoring the onset of expression of mRNAs for
procollagens type II α1 (Col2a) and type X α1 (Col10a),
respectively, as markers [15,16] (data not shown; the Col10a
gene was included also in the microarray, see Supplementary
Table 2, No. 200).
Poly(A)+ RNAs derived from ATDC5 cells at 7, 14, 21, and
28 days after chondrogenic induction with the differentiation
medium, and control ATDC5 cells without the induction, were
subjected to cDNA synthesis-coupled Cy3 and Cy5 labeling,
respectively, at least in duplicate. Both labeled cDNAs were
mixed in equal amounts and hybridized to a microarray.
Labeling vice versa with respect to Cy3 and Cy5 was also done
to correct a possible difference in incorporation efficiency of
these dyes, and in total at least four results of the hybridization
analysis at each time point were averaged. At 7, 14, 21, and 28
days, respectively 59, 97, 165, and 272 genes were up-
regulated, while 57, 122, 85, and 106 genes were down-
regulated 1.5-fold or more. Combining these up- and down-
regulated genes, 507 genes were up- or down-regulated 1.5-fold
or more at at least one time point after chondrogenic induction
(Supplementary Table 2).
To verify the results of our in-house cDNA microarray
system, we performed real-time RT-PCR analysis for 9 genes
arbitrarily selected from 272 genes up-regulated at 28 days
(Fig. 2): adrenomedullin (Adm; Entrez Gene No. 11535),
Fig. 2. Time courses of changes in mRNA levels for several genes during differentiation of ATDC5 cells. Results of microarray analysis (open squares) were compared
with those of real-time RT-PCR analysis (closed circles) at various time points after chondrogenic induction of ATDC5 cells. Genes for the PCR analysis were selected
arbitrarily from those up-regulated at 28 days in microarray analysis: adrenomedullin (Adm), cytoplasmic polyadenylation element binding protein (Cpeb), decorin
(Dcn), Ets variant gene 6 (Etv6), interferon regulatory factor 7 (Irf7), integral membrane protein 2B (Itm2b), osteomodulin (Omd), syndecan 2 (Sdc2), and SPARC-like
1 (Sparcl1). RNAs were prepared in duplicate from cell mixtures derived from 10 dishes or more at each time point. The values for the microarray analysis are
represented as the means ± SE for at least four hybridization experiments (see the text) and those for the PCR analysis as the means ± range for two reactions.
54 A. Osawa et al. / Genomics 88 (2006) 52–64cytoplasmic polyadenylation element binding protein (Cpeb;
12877), decorin (Dcn; 13179), Ets variant gene 6 (Etv6;
14011), interferon regulatory factor 7 (Irf7; 4123), integral
membrane protein 2B (Itm2b; 16432), osteomodulin (Omd;
27047), syndecan 2 (Sdc2; 15529), and SPARC-like 1
(Sparcl1; 13602). Real-time RT-PCR analysis confirmed the
up-regulation of these genes during the course of ATDC5
cell differentiation, while the dynamic range for detection of
changes in mRNA levels seems to be extended in the real-
time RT-PCR analysis compared to the microarray analysis
(Fig. 2). Expression of these genes in developing mouse
long bones was also confirmed with RT-PCR (data not
shown). Some of these genes have been shown or suggested
to be involved in chondrogenesis and/or osteogenesis.Adrenomedullin has been reported to stimulate [17] or
inhibit [18] proliferation of articular chondrocytes. Decorin
and osteomodulin are members of the SLRP family [12,13]
that will be referred to specifically under Discussion. Sparcl1
is the ancestral gene of the secretary calcium-binding
phosphoprotein family [19]. Sdc2 is a coreceptor of the
FGF receptor, and they are coexpressed in osteoblasts (see
below) [20].
All of the 507 up- and down-regulated genes with several
duplications were subjected to clustering analysis based on
expression patterns with the algorithm of Cosine and Ward in
the GeneMaths software and were classified into five clusters
(Fig. 3 and Supplementary Table 2). The expression patterns of
the majority of genes in each cluster can be characterized as
Fig. 3. Gene expression profiles during chondrogenic differentiation in ATDC5 cells. (Left) A total of 507 genes up- or down-regulated 1.5-fold or more at at least one
time point after chondrogenic induction were classified into five clusters using the algorithm of Cosine and Ward in the GeneMaths software. Time courses of changes
in mRNA levels of each gene are shown. Averaged mRNA levels represented by circles and gray lines are superimposed in each cluster. (Right) The time courses for
genes left after elimination of those exhibiting mRNA levels outside the range of mean ± 2 SD at any time point in each cluster are shown.
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transient decrease; Cluster C, lagging increase; Cluster D,
gradual increase; and Cluster E, transient increase.
We also classified the 507 genes according to their functions:
cell growth and maintenance, RNA turnover, protein turnover
and processing, signal transduction, metabolism, transmem-
brane and extracellular proteins, growth factor and cytokine
pathways, cytoskeleton, others, and unknown. The frequencies
of these functionally classified genes in total and in each cluster
are shown in Fig. 4 (see also Supplementary Table 2). InClusters A, B, and C, genes in the categories protein turnover
and processing, metabolism, and growth factor and cytokine
pathways were significantly frequent, respectively.
Genes in the category growth factor and cytokine pathways
in Cluster C and other clusters sum up to 24 and are listed in
Table 1. The functions of members of this category can be
further classified into four subcategories: (1) growth factors and
cytokines as well as chemokines, (2) their extracellular binding
proteins, (3) their receptors and associated proteins, and (4) their
target genes.
Fig. 4. Distribution of functionally categorized genes in each cluster. Genes were
classified based on their molecular functions with reference to Gene Ontology.
Significantly high (**p < 0.01; *p < 0.05) frequencies were evaluated by
Fisher's exact test.
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fold up- or down-regulation (338 genes) gave similar results,
and significant enrichment (10 of 18 genes, p < 0.05) of genes in
the category growth factor and cytokine pathways in the cluster
for 105 genes exhibiting an expression pattern of lagging
increase (data not shown). Clustering analysis using another
algorithm, SOM in the Adadis software, with the cut-off value
of 1.5-fold also showed significant enrichment (5 genes,
p < 0.05) of growth factor and cytokine pathways genes inthe cluster (33 genes) for gradually up-regulated genes (data not
shown).
Expression profiles of decorin and osteoglycin genes
Decorin and osteoglycin in Cluster C, and asporin in Cluster
E, are members of the SLRP family. While decorin [21,22] and
asporin [23] are known to bind with transforming growth
factors (TGF)-β, osteoglycin interacts with BMPs [24], which
constitute a subfamily of the TGF-β superfamily and which are
crucial for endochondral ossification [1,25]. As described
above, osteomodulin in Fig. 2 is also a member of the SLRP
family, while its interaction with growth factors and cytokines
remains to be examined. We here focused on decorin and
osteoglycin genes, both of which belonged to Cluster C and
appeared to be expressed strongly in the late phase of
chondrocyte differentiation (Table 1). We carried out Northern
analysis to examine changes in mRNA levels of decorin
(Fig. 5A) and osteoglycin (Fig. 5B) during differentiation of
ATDC5 cells (left) and development of long bones of mouse
extremities (right). Decorin and osteoglycin mRNAs were
detected as a single band of approximately 2.5 and 3.0 kb
length, respectively. Concordant with results of microarray
and real-time RT-PCR analysis (Fig. 2), decorin mRNA
levels increased prominently between 21 and 28 days during
ATDC5 differentiation (Fig. 5A, left). On the other hand,
osteoglycin mRNA levels increased gradually during the
differentiation course (Fig. 5B, left). In long bones of
developing mice, decorin mRNA levels increased during late
embryonic stages and slightly decreased at postnatal day 3
(P3) (Fig. 5A, right). Osteoglycin mRNA levels were almost
constant in late embryos and remarkably decreased at P3
(Fig. 5B, right). Apparently, changes in expression of the
osteoglycin gene precede those of the decorin gene during
the developmental course, its biological meaning left to be
clarified.
In situ hybridization analysis of the proximal region of the
tibia in E16 mice with antisense cRNA probes for decorin
(Fig. 6A) and osteoglycin (Fig. 6G), but not with sense
probes (Figs. 6B and 6H, respectively), revealed positive
signals in hypertrophic chondrocytes. With higher magnifi-
cation, strong signals were apparent in the cytoplasm (Figs.
6C and 6I, respectively). Also in the tibia of P3 mice, decorin
and osteoglycin mRNA signals were detected in hypertrophic
chondrocytes (Figs. 6D and 6J, respectively). In addition to
the tibia, decorin and osteoglycin mRNAs were detected in
hypertrophic chondrocytes of the scapula (Figs. 6E and 6K,
respectively) and the pelvis (Figs. 6F and 6L, respectively) in
E16 mice. These mRNAs were also detected in hypertrophic
chondrocytes of distal regions of the femur and tibia and
several foot bones of E16 and P3 mice, in an antisense
probe-specific manner (data not shown). Previous in situ
hybridization studies revealed expression of the decorin gene
mainly in the dermis of skin and organ-lining layers and not
bones in the late embryonic stages of mice [26,27]. The
reason for this discrepancy remains to be investigated, but
might be attributable to differences in probes (positions and
Table 1
Genes for the category “growth factor and cytokine pathways” in each cluster
Cluster Subcategory Symbol Gene name Accession
No.
Entrez
Gene
No.
Fold change
7 days 14 days 21 days 28 days
A Target genes Tgfbi Transforming growth factor, β induced L19932 21810 0.69 0.55 0.36 0.46
B Growth factors and
cytokines a
Cxcl12 Chemokine (C-X-C motif) ligand 12 D43804 20315 0.76 0.70 0.59 0.97
C Growth factors and
cytokines
Bdnf Brain-derived neurotrophic factor D10938 12064 1.04 1.74 0.63 2.25
C Growth factors and
cytokines
Ccl9 Chemokine (C-C motif) ligand 9 U15209 20308 0.54 0.98 1.98 1.92
C Growth factors and
cytokines
Cxcl10 Chemokine (C-X-C motif) ligand 10 M33266 15945 1.08 1.24 0.83 4.24
C Growth factors and
cytokines
Pbef Pre-B-cell colony-enhancing factor U02020 59027 0.89 1.01 1.37 2.10
C Growth factors and
cytokines
Pdgfb Platelet-derived growth factor,
B polypeptide
AI131599 18591 2.94 0.12 9.42 1.06
C Growth factors and
cytokines
Ptn Pleiotrophin E03564 19242 0.58 1.20 1.20 1.09
C Growth factors and
cytokines
Tgfb2 Transforming growth factor, β2 X57413 21808 1.08 1.13 0.97 3.57
C Receptors and
associated proteins
Ly86 Lymphocyte antigen 86 AB007599 17084 1.19 0.71 1.27 1.82
C Receptors and
associated proteins
Tnfrsf12a Tumor necrosis factor receptor superfamily,
member 12a
AK013438 27279 1.00 0.93 1.33 2.24
C Extracellular binding
proteins
Dcn Decorin X53929 13179 0.84 1.54 2.82 7.09
C Extracellular binding
proteins
Ogn Osteoglycin AI596220 18295 1.12 3.11 2.16 6.35
C Target genes Ifi203 Interferon-activated gene 203 BC008167 15950 0.96 2.31 1.39 2.25
C Target genes Ifit3 Interferon-induced protein with
tetratricopeptide repeats 3
L32974 15959 1.83 2.91 1.69 6.48
C Target genes Rqcd1 Rcd1 (required for cell differentiation)
homolog 1 (Saccharomyces pombe)
D87957 58184 1.57 0.92 0.97 1.63
D Growth factors and
cytokines
Scgf Stem cell growth factor BC002001 20256 2.54 2.05 1.64 1.91
D Receptors and
associated proteins
Il17r Interleukin 17 receptor AI118542 16172 0.83 1.10 2.17 1.97
D Extracellular binding
proteins
Igfbp4 Insulin-like growth factor binding protein 4 AI118543 16010 1.51 3.38 3.98 7.35
D Extracellular binding
proteins
Sdc2 Syndecan 2 U00674 15529 1.40 3.94 2.11 2.14
D Target genes Ifi47 Interferon-γ-inducible protein M63630 15953 1.52 >100 >100 >100
E Growth factors and
cytokines
Csf1 Colony stimulating factor 1 (macrophage) M81316 12977 0.40 >100 0.77 3.50
E Growth factors and
cytokines
Pf4 Platelet factor 4 AB017491 56744 2.53 1.00 1.23 1.29
E Extracellular binding
proteins
Aspn Asporin AA986886 66695 >100 2.52 1.89 10.35
a The subcategory “growth factors and cytokines” also includes chemokines.
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conditions.
Discussion
In the post-genome-sequencing era, preparation of resources
for functional genomics is imperative. Cloning and sequencing
of full-length cDNAs is beneficial for clarification of coding
sequences and subsequent functional analysis. We constructed a
full-length-enriched cDNA library derived from differentiating
ATDC5 cells and developing mouse bone and cartilage and thenprepared an in-house cDNA microarray that is highly efficient
in identifying genes associated with chondrogenesis. Results of
the microarray analysis for changes in expression of selected
genes during the ATDC5 differentiation were confirmed by
real-time RT-PCR analysis. Thus, our in-house cDNA micro-
array system is an excellent tool for analyzing expression
profiles of many genes in this field. Characterization of a large
number of differentially expressed genes should provide
valuable information on chondrogenesis.
As shown in Fig. 4, genes in the category protein turnover
and processing were frequent in Cluster A, characterized by
Fig. 5. Northern analysis of (A) decorin and (B) osteoglycin. Time courses of changes in mRNA levels for decorin and osteoglycin during differentiation of ATDC5
cells derived from 10 dishes or more at each time point (left) and from long bones derived from extremities of about 10 mice (right) were examined by RNA blot
analysis. Positions of the 28S and 18S rRNAs are shown. Below the chemiluminograms, quantified mRNA levels relative to the maximum value (100%) are
represented.
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related to decreasing proliferation rates of ATDC5 cells during
differentiation. On the other hand, enrichment of genes in the
category metabolism in Cluster B with the feature of transient
decreases is concordant with the notion that a variety of genes
for metabolism are repressed during proliferation.
Genes in the category growth factor and cytokine pathways
were frequent in Cluster C, characterized by lagging increases
in expression of a number of genes, apparently reflecting
complicated developmental and physiological roles of chon-
drocytes in late differentiation stages. Decorin and osteoglycin
found in the list for these genes (Table 1) are members for the
family of SLRPs, which are characterized by 6–10 tandem
leucine-rich repeats of 20–30 amino acid residues. In humans
and mice, the SLRP family comprises at present 13 members,
which can be synthesized either as glycoproteins containing
oligosaccharides or as proteoglycans containing chondroitin/
dermatan sulfate or keratan sulfate chains [12,13]. Three classes
of SLRPs were identified based on conservation of overallamino acid sequences, the presence of distinct cysteine-rich
regions, and genomic organization. Decorin belongs to class I,
while osteoglycin to class III of SLRPs. Asporin in Cluster E of
Table 1 and osteomodulin in Fig. 2 are also members of the
SLRP family and belong to class I and II, respectively.
Decorin and osteoglycin are extremely interesting in the
context of endochondral bone formation, because of their
potentially interdigitated roles. Decorin and osteoglycin interact
with TGF-βs [21,22] and BMPs [24], respectively. BMPs
represent almost one-third of the TGF-β superfamily [25].
Decorin enhances [28] or inhibits [21] TGF-β-dependent cell
proliferation. Interestingly, genes for decorin and TGF-β2
exhibited similar time courses in their expression pattern
(Cluster C in Table 1) during ATDC5 differentiation, suggesting
overlapped expression and interaction of these proteins during
chondrogenesis. Osteoglycin, also named mimecan [29], was
originally isolated from bovine bone as the osteoinductive
factor [30]. Later, osteoglycin was shown to copurify with and
then suggested to bind to BMP2 and BMP3 [24], which account
Fig. 6. In situ hybridization analysis for mRNAs of (A–F) decorin and (G–L) osteoglycin. (A–C, G–I) Longitudinal sections of the proximal regions of the E16 tibia
were probed with (A, G) antisense cRNA and (B, H) sense cRNA as a control. (C, I) Higher magnification views of the hypertrophic zone of (A) and (G), respectively.
(D, J) Longitudinal sections of the P3 tibia. (E, K) Sagittal sections of the E16 scapula. (F, L) Sagittal sections of the E16 pelvis. Arrows indicate hypertrophic zones,
and open arrowheads mark artificial structures.
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appear to be carrier molecules holding and releasing TGF-βs
and BMPs, respectively, in the ECM space. BMPs play multiple
important roles in nearly all processes during skeletal
morphogenesis and especially in later stages of cartilage
development [1,25]. TGF-βs enhance proliferation in early
undifferentiated stages of chondrogenesis, but inhibit terminalchondrocyte differentiation in a number of culture systems
[31,32]. When combined with BMP2 and BMP3, TGF-β2
potentiates both cartilage and bone formation [24].
Decorin is involved in another growth factor pathway and
binds with the epidermal growth factor (EGF) receptor, leading
to its increased phosphorylation, activation of the mitogen-
activated protein kinase pathway, an up-regulation of p21, and
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resulting in modifications of collagen structure and function
such as inhibition of collagen fibril formation [34], collagen
phagocytosis by fibroblasts [36], and collagen calcification by
osteoblasts [37]. Thus, decorin is a multifaceted protein
interacting with TGF-βs, the EGF receptor, and collagens.
This unique property tempts us to speculate that decorin and
other SLRP family members play pivotal roles in multiple tasks
of hypertrophic chondrocytes, where coexpression of decorin
and osteoglycin takes place as suggested in this study (Fig. 6).
Hypertrophic chondrocytes enlarge themselves to meet bone
growth, mineralize their surrounding matrix, induce bone collar
osteoblasts, attract blood vessels and osteoclasts, and undergo
apoptotic cell death, leaving cartilage matrix for a scaffold for
invading osteoblasts that lay down a true bone matrix [1]. The
multifaceted SLRP family members are candidates for factors
coordinating several of these steps.
Very recently, real-time PCR analysis of 104 genes during
differentiation of ATDC5 cells [38] and Affymetrix microarray
analysis during chondrogenic differentiation in a mouse
micromass culture system [39] were reported. The decorin
gene was included also in the list of up-regulated genes in the
latter work.
In addition to decorin and osteoglycin, a number of genes in
Table 1 have been shown or suggested to be involved in
chondrogenesis and osteogenesis, as well as angiogenesis and
hematopoiesis. The TGF-β-induced protein (also named βig-
h3) in Cluster A is an ECM protein inhibiting angiogenesis [40]
and osteoblast differentiation [41] through interaction with cell
surface integrins. Down-regulation of this gene during chon-
drocyte differentiation (Table 1) might facilitate osteogenesis
and angiogenesis. Chemokine (C-X-C motif) ligand (CXCL) 12
in Cluster B is also known as stromal cell-derived factor 1 and is
involved in the chemoattraction of a number of cell types such
as hematopoietic stem cells [42]. CXCL12 was recently shown
to chemoattract circulating osteoclast precursors developing to
bone-resorptive osteoclasts [43] and also to activate mature
osteoclasts [44]. Cxcl12 is down-regulated transiently in the
middle phase during the course of differentiation of ATDC cells
(Table 1), its biological meaning left to be clarified.
Brain-derived neurotrophic factor, a representative neuro-
trophin, in Cluster C was recently shown to be synthesized also
by endothelial cells and involved in angiogenesis in an
autocrine or paracrine manner [45]. Chemokine (C-C motif)
ligand 9 is also known as MIP-1γ, MRP-2, and CCF18, and has
been shown to be the major chemokine ligand species of
osteoclasts [46]. CXCL10 induces alkaline phosphatase and β-
N-acetylhexosaminidase in osteoblasts [47]. Pre-B cell colony-
enhancing factor, originally identified as a putative growth
factor for early B cell development [48], also exhibits an
inhibitory activity for neutrophil apoptosis [49]. Platelet-
derived growth factor B polypeptide stimulates chondrocyte
proliferation, apparently reflecting a role in bony repair after
injury [50,51]. Pleiotrophin, also named OSF-1, exhibits
multiple effects on chondrocyte proliferation and differentia-
tion, depending on concentration and timing of action [52,53].
Tumor necrosis factor (TNF) receptor superfamily member(TNFRSF) 12a was identified as the fibroblast growth factor-
inducible-14 (Fn14) gene [54] and is a receptor [55] for a TNF
family member that weakly induces apoptosis [56].
TNFRSF12a/Fn14 seems to be involved also in angiogenesis
[55]. RQCD1/RCD1/FL10 was initially identified as a factor
required for commitment to nitrogen starvation-invoked
differentiation in fission yeast [57]. Mammalian RQCD1
plays a role in the commitment step of retinoic acid-induced
differentiation [58]. Rqcd1 transcripts are induced by erythro-
poietin in hematopoietic cells [59].
Stem cell growth factor in Cluster D is a cytokine for
primitive hematopoietic progenitor cells [60]. The interleukin
17 (IL-17) receptor seems to mediate the effect of IL-17 in
combination with TNF-α for osteoclastic resorption [61].
Syndecan (Sdc) 2, as well as other members of the Sdc family,
is a coreceptor of FGF receptors, and its coexpression with FGF
receptors in osteoblasts has been demonstrated [20]. Insulin-like
growth factor (IGF) binding protein 4 (IGFBP4) exhibits
osteogenic activity apparently through binding and releasing
IGF with coupled proteolysis of IGFBP4 [62,63].
Colony stimulating factor (CSF) 1 in Cluster E is essential
for osteoclastogenesis and is also involved in endochondral
bone formation, being revealed by studies on Csf1-mutant
mouse and rat that suffer from osteopetrosis [64,65]. Asporin is
a member of the SLRP family [66,67]. Recently, it was shown
that an aspartic acid (D) repeat polymorphism (14 D residues) is
associated with osteoarthritis and that asporin having 14 D
residues inhibits TGF-β activity more strongly than common
asporin having 13 D residues, seemingly through direct binding
between asporin and TGF-β resembling that between decorin
and TGF-β [23].
Some of these factors in Cluster C and other clusters may
participate in the regulation of proliferation and differentiation
of chondrocytes in an autocrine and/or paracrine manner, as
well as in chemoattraction and further functional regulation of
penetrating blood vessels, osteoprogenitor cells, and hemato-
poietic cells. The fact that the majority of these genes converge
to the same group (Cluster C) may imply functional
cooperativity and coordinated regulation of the genes. Clarifi-
cation of function and regulation of these genes will provide
insights into the complicated mechanisms of endochondral bone
formation.
In summary, our in-house cDNA microarray system
allowed us to investigate gene expression profiles during
chondrogenic differentiation of ATDC5 cells. A number of
genes involved in growth factor and cytokine pathways
showed the characteristic feature of activation in late phases
in the differentiation course. Among them, genes for decorin
and osteoglycin, members of the SLRP family for multifaceted
ECM proteins interacting with growth factors/cytokines and
other proteins, were shown to be expressed in hypertrophic
chondrocytes of developing mouse bones. A tempting
speculation is that the SLRP family members and other factors
induced late in chondrogenesis play roles in multiple tasks of
hypertrophic chondrocytes, and they can be candidates for
molecular targets of diagnosis and treatment of bone and
cartilage disorders.
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Cell culture condition
Mouse chondrogenic ATDC5 cells were cultured in the maintenance
medium made by a 1:1 mixture of DME medium and Ham's F-12 medium
(Flow Laboratories, Irvine, UK) containing 5% FBS (GIBCO BRL, Gaithers-
burg, MD, USA), 10 μg/ml human transferrin (Boehringer GmbH, Mannheim,
Germany), and 30 nM sodium selenite (Sigma Chemical Co., St. Louis, MO,
USA), at 37°C in a humidified atmosphere of 5% CO2 in air, according to
previous reports [9,10]. Thirty thousand cells of inoculum size were seeded in a
10-cm plate (Corning, Corning, NY, USA). To induce chondrogenesis, cells
were cultured in the maintenance medium supplemented with 10 μg/ml bovine
insulin (Wako Pure Chemical, Osaka, Japan). We defined this specific medium
as “differentiation medium.” The medium was replaced every other day.
Mouse cartilage and bone tissues
Pregnant mice were obtained from CLEA Japan, Inc. (Tokyo, Japan). Long
bones of extremities were collected from fetuses on embryonic days 14, 15, and
17 and from newborn mice on postnatal day 3, under three-dimensional
microscopy. All animal treatments were performed in accordance with the law
(No. 105) and notification (No. 6) of the Japanese Government and with the
institutional guidelines for the care and use of laboratory animals at Chiba
University.
mRNA preparation
Total RNA was prepared from ATDC5 cells, mouse bones, and mouse
embryos using TRIzol reagent (Invitrogen Co., Carlsbad, CA, USA) and
subjected to isolation of poly(A)+ RNA using the Oligotex-dt30 mRNA
purification kit (Takara Shuzo Co., Kyoto, Japan) according to the manufac-
turer's instructions.
Construction of a full-length-enriched cDNA library and an in-house
cDNA microarray
A full-length-enriched cDNA library was constructed by the oligo-capping
method as previously described [11] using 500 μg of total RNA from various
stages of differentiated ATDC5 cells and mouse cartilage and bone tissues.
Construction of the cDNA library for mouse embryos (E14) was described
previously [14]. The cDNA clones were randomly picked from libraries, and
their 5′-end nucleotide sequences were determined using a Dye Terminator
Cycle Sequencing kit (Applied Biosystems Japan, Tokyo, Japan) and an ABI
3700 DNA sequencer. A cDNA microarray containing these cDNA clones was
constructed as described previously [68]. Briefly, 2 mg/ml PCR-amplified
cDNAs were mixed in a 1:1 ratio with 4 mg/ml nitrocellulose in dimethyl
sulfoxide immediately before printing and then spotted onto carbodiimide-
coated glass slides (Nisshinbo, Chiba, Japan) using a robotic system (SPBIO-
2000; Hitachi Software Engineering Co., Tokyo, Japan). Murine β-actin cDNA
was also spotted on the same array to serve as an internal control. After drying,
printed PCR products were crosslinked with ultraviolet light using a UV
crosslinker (60 mJ/cm2; Amersham Pharmacia Biotech, Piscataway, NJ, USA)
and stored at room temperature.
Fluorescent targets
Cy3–dUTP or Cy5–dUTP (Amersham Pharmacia Biotech) was incorpo-
rated into cDNA during reverse transcription of poly(A)+ RNA, using an oligo
(dT) primer. The poly(A)+ RNA derived from at least 10 dishes of ATDC5 cells
at each time point of 7, 14, 21, and 28 days after induction of chondrogenesis
was subjected to Cy3 labeling and that from control ATDC5 cells to Cy5
labeling. We also inverted labeling for the Cy3 and Cy5 fluorochromes. Two
micrograms of poly(A)+ RNA and 4.5 μg of the oligo(dT) primer were dissolved
in 15.4 μl of H2O, heated to 70°C for 10 min, and immediately chilled on ice.
Six microliters of SuperScript II buffer (Invitrogen), 3 μl of 0.1 M DTT, 0.6 μl of
dNTP (25 mM dATP, dCTP, and dGTP and 10 mM dTTP), and 3 μl of 1 mMCy3–dUTP or Cy5–dUTP were serially added to the RNA solution. Finally 400
U (2 μl) of SuperScript II was added, and the reaction was incubated at 42°C for
1 h. At this point, a further 200 U (1 μl) of SuperScript II was added to the
reaction mixture, and the mixture was incubated at 42°C for an additional 1 h.
Once the reaction was complete, RNA was degraded by adding 1.5 μl of 1 M
NaOH/20 mM EDTA followed by a 10-min incubation at 65°C. The samples
were neutralized by addition of 270 μl of 10 mM Tris–HCl (pH 8.0)/1 mM
EDTA (TE) and 1.5 μl of 1 MHCl. Unincorporated fluorescent nucleotides were
removed using Centricon-30 microconcentrators (Millipore/Amicon, Bedford,
MA, USA), concentrating the mixture into a volume of 10 μl or less. Twenty
micrograms of salmon sperm DNA and 500 μl of TE were added to the probe
solution, which was then concentrated to 10 μl.
Hybridization and scanning
The fluorescent targets derived from chondrogenesis-induced ATDC5 cells
and uninduced control cells were mixed with 50 μg of yeast RNA (Sigma
Chemical Co.), 50 μg of poly(A) (Roche Diagnostics Co., Basel, Switzerland),
4.25 μl of 20× SSC (1× SSC: 0.15MNaCl/15mM sodium citrate), and 0.75 μl of
10% SDS and then adjusted to a total volume of 25 μl with H2O. The target
mixture was heated at 100°C for 2 min and incubated for 30 min at room
temperature before usage. Prior to hybridization, the microarray was incubated
with blocking buffer containing 3%BSA, 0.2MNaCl, 0.1M Tris–HCl (pH 7.5),
and 0.05% Triton X-100 for 30 min at room temperature and then thoroughly
dried at 37°C. After three washes with TE, the array was dried by centrifugation
at 1000 rpm for 1 min. The 25-μl target mixture was applied onto the microarray
surface and covered with a coverslip (24 × 40 mm; Matsunami, Osaka, Japan).
The array was transferred to a hybridization chamber and incubated at 65°C
overnight under humidified conditions. The array was washed twice for 5 min at
room temperature in low-stringency wash buffer consisting of 2× SSC and 0.1%
SDS and twice for 5 min at 40°C in high-stringency wash buffer consisting of
0.2× SSC and 0.1% SDS and then rinsed with 0.2× SSC. The array was dried by
centrifugation at 1000 rpm for 1 min and then scanned with the use of a
fluorescence laser-scanning device (ScanArray4000; GSI Lumonics, Nepean,
Canada). Images were analyzedwith Quant Array software (GSI Lumonics). The
mean intensity of the background was subtracted from the intensity of each spot
on each block. The first filter excluded genes with intensities of less than the
mean plus 1 SD of background levels at each block. The Cy3/Cy5 or Cy5/Cy3
ratios (induced ATDC5/uninduced ATDC5 ratios) of all spots on the microarray
were normalized by dividing each ratio by the median ratio. The second filter
selected genes with normalized ratios shifted at least 1.5-fold.
Annotation of gene functions and statistical analysis
The molecular functions of genes were assigned with reference to Gene
Ontology (http://www.geneontology.org/) and were classified into 10 groups:
cell growth and maintenance, RNA turnover, protein turnover and processing,
signal transduction, metabolism, transmembrane and extracellular proteins,
growth factor and cytokine pathways, cytoskeleton, others, and unknown.
Clustering analysis for time-course patterns of gene expression was done using
the algorithm of Cosine and Ward in the GeneMaths software (Applied Maths
BVBA, Sint-Martens-Latem, Belgium) and of SOM in the Adadis software
(Strand Life Sciences, Bangalore, India). To examine statistical significance for
frequencies of functionally categorized genes in each cluster, values of the other
groups in the relevant cluster and values of other clusters in the relevant group
were analyzed with Fisher's exact test by computing with the statistical program
StatView (SAS, Cary, NC, USA).
Analysis of mRNA levels by the real-time RT-PCR procedure
ATDC5 cells derived from at least 10 dishes at each time point were mixed
and subjected to preparation of total RNA. To test the validity of results obtained
by the microarray analysis, nine genes were arbitrarily selected from genes up-
regulated at 28 days, and their mRNA levels were determined by the real-time
RT-PCR procedure, using the SYBR green PCR system with a Lightcycler
fluorescence rapid-air cycler according to the manufacturer's instructions
(Roche Diagnostics). PCR experiments were performed twice, and the results
were averaged.
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The decorin cDNA segment at positions 448–734 (Accession No. X53929)
and the osteoglycin cDNA segment at positions 1022–1421 (AI596220) were
amplified by PCR using cognate cDNA clones as templates and were inserted
into the plasmid vector pGEM-T (Promega, Madison, WI, USA), according to
the instructions of Promega. Resulting plasmids were linearized with
appropriate restriction enzymes and subjected to synthesis of digoxigenin-
labeled sense and antisense cRNA probes with SP6 or T7 RNA polymerase,
according to the instructions of Roche Diagnostics.
RNA blot analysis
Total RNA (2 μg per lane) was electrophoresed in denaturing formalde-
hyde–agarose (1%) gels. After visualizing 28S and 18S rRNAs by ethidium
bromide staining to check the integrity of the RNA samples and equal loading,
RNA was transferred onto nylon membranes. Hybridization, washing, and
chemiluminescence detection of hybridized probes on X-ray films with alkaline
phosphatase-conjugated anti-digoxigenin antibody were done as recommended
by Roche Diagnostics. Densitometric quantification was performed by using
Personal Scanning Image PDSI (Molecular Dynamics, Sunnyvale, CA, USA).
Tissue preparation and in situ hybridization
Pregnant mice were obtained from CLEA. Lower legs were collected from
fetal mice on E16 and newborn mice on P3 (bone tissues of the P3 legs were
exposed by removing skin and muscles) and fixed with 4% paraformaldehyde in
PBS at 4°C overnight. The P3 bone tissues were decalcified with Morse's
solution (10% sodium citrate and 22.5% formic acid) [69,70] for 12 h. Legs and
bone tissues were dehydrated in serially concentrated ethanol and xylene and
embedded in paraffin. Tissue sections were cut and mounted on glass slides
coated with 3-aminopropyltriethoxysilane. Sagittal sections for whole mouse
embryos (E16) were purchased from Novagen–Merck (EMD, San Diego, CA,
USA). Dewaxing was done by heating the slides in an oven at 60°C for 1 h
followed by immersions in xylene three times (30, 15, 15 min). The slides were
then rehydrated in serially diluted ethanol (95, 70, 30%) and in PBS. The
sections were subjected to digestion in 1 μg/ml proteinase K in PBS for 10 min,
followed by washing in PBS. The sections were fixed with 4% paraformalde-
hyde in PBS and thoroughly washed in PBS. Prehybridization, hybridization
with digoxigenin-labeled cRNA probes, washing, and color detection of the
hybridized probes with alkaline phosphatase-conjugated anti-digoxigenin
antibody and chromogens nitroblue tetrazolium chloride and 5-bromo-
4-chloro-3-indolyl phosphate were done essentially as described [71]. Hybri-
dization and washing temperatures were 45–50°C.Acknowledgments
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